ArticleFrontiers in immunology2025
Immunomodulatory and anticancer effects of moringa polyherbal infusions: potentials for preventive and therapeutic use.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bioactivity-guided analysis of Moringa olifera fractionated extracts for potential medical application.Scientific reports · 2026Article
- HarnessingInternational journal of molecular sciences · 2025Review
- Bee venom and thymoquinone combination inhibits cancer cells by inducing cell cycle arrest and apoptosis.Scientific reports · 2025Article
- Effect of Moringa oleifera and ivermectin nanoparticles on the immunopathological response during experimental trichinosis in mice.Gut pathogens · 2025Article
- Anti-Cancer and Immunomodulatory Activities ofIntegrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Plant-based phytochemicals have shown potential as agents against cancer through various biological pathways, including immune system modulation. Combining natural compounds with synergistic interactions enhances the identification of molecular targets in cancer cells, demonstrating anticancer capabilities. The "miracle tree," Aim: This study assesses the anti-tumor and immunomodulatory characteristics of Methods: The MTT assay evaluated the anti-proliferative effectiveness of uncombined Results: The anti-proliferative activity of Moringa-saffron showed the strongest anti-proliferative effect on T47-D and EMT6/P, with IC Conclusion: When combined with saffron or green tea, Moringa can effectively combat cancer and enhance immunomodulatory properties. Further studies are needed to understand the mechanism of action of these herbal infusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.